Russia approves first COVID-19 prescription drug for sale in pharmacies

MOSCOW - Russia has approved R-Pharm's Coronavir treatment for outpatients with mild to moderate COVID-19 infections and the antiviral drug could be rolled out to pharmacies in the country as soon as next week, the company said on Friday.

R-Pharm's announcement is another sign Russia is pushing hard to take a global lead in the race against the virus. It is already exporting its COVID-19 tests and has clinched several international deals for supplies of its Sputnik-V vaccine. The drug was first approved for in-hospital use to treat COVID-19 in July, a government register showed.

R-Pharm has started talks with pharmacies about orders, the company's spokeswoman said, with Coronavir supplies expected to be rolled out in the near future, possibly as soon as next week.Avifavir has been available in hospitals since June but has yet to be supplied to pharmacies.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Russia to sell 100 million doses of COVID-19 vaccine to India - sourceRussia's sovereign wealth fund has agreed a deal to sell 100 million doses of its COVID-19 vaccine, Sputnik-V, to a major listed pharmaceutical company in India, a source close to the deal said on Wednesday. Clinical trials of the Russian vaccine in India are expected to follow and to be held jointly
Source: YahooSG - 🏆 3. / 71 Read more »